MaxCyte buys into CAR-T with Johns Hopkins partnership

Damian Garde

Maryland biotech is delving the world of CAR-T treatments for cancer, teaming up with University on a preclinical program.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS